Regarding the mechanism of action, it was further found that the epidermal growth factor receptor (EGFR) expression in pancreatic cancer cells could be reduced by retinoids such as ATRA, which was reflected by inhibition of EGFR ligand-induced proliferation [69,70]. Here, EGFR is linked to pancreatic neoplasm.